In subsequent studies on the effects of anti-IL-9 antibodies in experimental NSCLC, we explored the effects of these antibodies at later time points of tumor induction in the two models of disease in syngenic mice. This evidence concerns the gene IL9 and non-small cell lung carcinoma.